Varicella Vaccine: Genesis, Efficacy, and Attenuation
- 1 June 2001
- Vol. 284 (2) , 153-158
- https://doi.org/10.1006/viro.2001.0918
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Identification and Mapping of Single Nucleotide Polymorphisms in the Varicella-Zoster Virus GenomeVirology, 2001
- Varicella-Zoster Virus gE Escape Mutant VZV-MSP Exhibits an Accelerated Cell-to-Cell Spread Phenotype in both Infected Cell Cultures and SCID-hu MiceVirology, 2000
- Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activityJournal of Medical Virology, 2000
- Frequencies of Memory T Cells Specific for Varicella‐Zoster Virus, Herpes Simplex Virus, and Cytomegalovirus by Intracellular Detection of Cytokine ExpressionThe Journal of Infectious Diseases, 2000
- Nucleotide Sequences that Distinguish Oka Vaccine from Parental Oka and Other Varicella?Zoster Virus IsolatesThe Journal of Infectious Diseases, 2000
- Varicella-Zoster Virus VaccineClinical Infectious Diseases, 1997
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.Proceedings of the National Academy of Sciences, 1993
- The Complete DNA Sequence of Varicella-Zoster VirusJournal of General Virology, 1986
- LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITALPublished by Elsevier ,1974